Market Cap 2.60B
Revenue (ttm) 475.68M
Net Income (ttm) 78.33M
EPS (ttm) N/A
PE Ratio 39.79
Forward PE 27.17
Profit Margin 16.47%
Debt to Equity Ratio 0.00
Volume 7,730,800
Avg Vol 2,763,258
Day's Range N/A - N/A
Shares Out 249.44M
Stochastic %K 21%
Beta 1.18
Analysts Strong Sell
Price Target $16.50

Company Profile

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking,...

Industry: Software - Infrastructure
Sector: Technology
Phone: 972 73 394 8000
Address:
94 Shlomo Shmelzer Road, Petah Tikva, Israel
kej32
kej32 Aug. 19 at 3:37 PM
$CLBT The expansion has begun! https://x.com/cellebrite/status/2090057485667188960?s=46&t=mTiPkuwMEr3cC5hX_MpFMA
0 · Reply
updiddlyup
updiddlyup Aug. 19 at 1:29 PM
$CLBT official https://apfs-cloud.dhs.gov/record/73738/public-print/
0 · Reply
updiddlyup
updiddlyup Aug. 19 at 1:09 PM
$CLBT Cellebrite is the chosen product solution already for the $100M project. The competing vendors are bidding for the actual rollout of the product. https://www.highergov.com/contract-forecast/cellebrite-indefinite-delivery-indefinite-quanti-1142655/#overview
0 · Reply
updiddlyup
updiddlyup Aug. 18 at 9:52 PM
$CLBT Institutions taking advantage. Voss Capital LP (Travis W. Cocke, Houston) has crossed 5% in Cellebrite. Aggregate 12,700,000 shares, 5.1% of the 250,785,933 ordinary shares outstanding as of 30 June 2026, per the share count in Exhibit 99.1 of the 6-K filed 13 August.
0 · Reply
updiddlyup
updiddlyup Aug. 18 at 9:20 PM
$CLBT 😎 The September federal contract https://fedscoop.com/wp-content/uploads/sites/5/2026/05/APFS-050626-Cellebrite-ICE.pdf DHS Acquisition Planning Forecast System record F2026073738, published 6 May 2026. ICE/HSI requirement out of the DHS Cyber Crimes Center. Titled as a brand name five-year Cellebrite IDIQ. Estimated dollar range $50M to $100M. Firm fixed price. Competition marked yes. NAICS 334290. Place of performance Fairfax VA. Estimated solicitation release 16 July 2026. Anticipated award Q4 FY2026. Contract complete 29 September 2031. Q4 FY2026 ends 30 September. The solicitation was due out a month ago, so on the forecast schedule roughly six weeks remain in the award window. The record description states Cellebrite mobile forensic products are the most widely deployed computer forensic tool within HSI, covering phones, tablets and unmanned aerial vehicles, across both domestic and international offices.
1 · Reply
updiddlyup
updiddlyup Aug. 18 at 8:14 PM
$CLBT that spike right at the end there is institutional block trades wiping out liquidity. [15:51:02 EST] 🟢 BLOCK TRADE: 45,000 shares @ $10.74 (Value: ~$483,300) [15:55:18 EST] 🟢 BLOCK TRADE: 72,500 shares @ $10.85 (Value: ~$786,625) [15:59:45 EST] 🔥 SWEEDING ORDER: 110,000 shares @ $10.98 (Value: ~$1,207,800)
2 · Reply
Eelco1054
Eelco1054 Aug. 17 at 3:34 PM
$CLBT Added
0 · Reply
Invest2Growcom
Invest2Growcom Aug. 17 at 2:19 PM
$CLBT I really love this stock at these levels. It has robust fundamentals and the valuation is yummy (NFA).
0 · Reply
punktdot
punktdot Aug. 17 at 2:16 PM
$CLBT it doesn't make any sense, who would be selling now?
1 · Reply
updiddlyup
updiddlyup Aug. 17 at 1:30 PM
$CLBT PING! darn I wanted more at 11. Will have to pay a bit more now
1 · Reply
Latest News on CLBT
Cellebrite says Shiven Ramji to succeed Thomas Hogan as CEO

2026-08-17T08:11:38.000Z - 2 days ago

Cellebrite says Shiven Ramji to succeed Thomas Hogan as CEO


Cellebrite falls -35.7%

2026-08-17T07:29:38.000Z - 2 days ago

Cellebrite falls -35.7%


Cellebrite falls -31.8%

2026-08-17T07:19:39.000Z - 2 days ago

Cellebrite falls -31.8%


Cellebrite price target lowered to $15 from $23 at TD Cowen

2026-08-16T14:16:02.000Z - 3 days ago

Cellebrite price target lowered to $15 from $23 at TD Cowen


Cellebrite price target lowered to $16 from $20 at JPMorgan

2026-08-16T13:38:13.000Z - 3 days ago

Cellebrite price target lowered to $16 from $20 at JPMorgan


Cellebrite DI Earnings Call Transcript: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 6 days ago

Cellebrite DI Earnings Call Transcript: Q2 2026


Cellebrite DI Earnings release: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 6 days ago

Cellebrite DI Earnings release: Q2 2026


Cellebrite DI Slides: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 6 days ago

Cellebrite DI Slides: Q2 2026


Cellebrite price target raised to $22 from $20 at DA Davidson

2026-08-06T13:27:11.000Z - 13 days ago

Cellebrite price target raised to $22 from $20 at DA Davidson


Cellebrite expands partnership with SkySafe

2026-07-08T12:35:33.000Z - 6 weeks ago

Cellebrite expands partnership with SkySafe


Cellebrite DI Transcript: Mizuho Technology Conference 2026

Jun 10, 2026, 11:15 AM EDT - 2 months ago

Cellebrite DI Transcript: Mizuho Technology Conference 2026


Cellebrite DI Transcript: Investor update

Jun 10, 2026, 9:00 AM EDT - 2 months ago

Cellebrite DI Transcript: Investor update


Cellebrite Announces Upcoming Investor Events on June 10, 2026

Jun 5, 2026, 8:00 AM EDT - 2 months ago

Cellebrite Announces Upcoming Investor Events on June 10, 2026


Cellebrite initiated with a Buy at DA Davidson

2026-05-26T20:42:46.000Z - 3 months ago

Cellebrite initiated with a Buy at DA Davidson


Cellebrite price target lowered to $15 from $18 at Needham

2026-05-15T14:33:45.000Z - 3 months ago

Cellebrite price target lowered to $15 from $18 at Needham


Cellebrite reports Q1 non-GAAP EPS 12c, consensus 9c

2026-05-14T13:16:13.000Z - 3 months ago

Cellebrite reports Q1 non-GAAP EPS 12c, consensus 9c


Cellebrite DI Earnings Call Transcript: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Cellebrite DI Earnings Call Transcript: Q1 2026


Cellebrite DI Earnings release: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Cellebrite DI Earnings release: Q1 2026


Cellebrite DI Slides: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Cellebrite DI Slides: Q1 2026


Cellebrite Announces First-Quarter 2026 Results

May 14, 2026, 7:00 AM EDT - 3 months ago

Cellebrite Announces First-Quarter 2026 Results


Cellebrite Government Cloud Achieves FedRAMP High Authorization

May 6, 2026, 8:30 AM EDT - 3 months ago

Cellebrite Government Cloud Achieves FedRAMP High Authorization


Cellebrite Files its 2025 Annual Report on Form 20-F

Mar 4, 2026, 8:30 AM EST - 6 months ago

Cellebrite Files its 2025 Annual Report on Form 20-F


Cellebrite DI Earnings Call Transcript: Q4 2025

Feb 11, 2026, 8:30 AM EST - 6 months ago

Cellebrite DI Earnings Call Transcript: Q4 2025


Cellebrite DI Annual report: Q4 2025

Feb 11, 2026, 8:30 AM EST - 6 months ago

Cellebrite DI Annual report: Q4 2025


Cellebrite DI Earnings release: Q4 2025

Feb 11, 2026, 8:30 AM EST - 6 months ago

Cellebrite DI Earnings release: Q4 2025


Cellebrite DI Slides: Q4 2025

Feb 11, 2026, 8:30 AM EST - 6 months ago

Cellebrite DI Slides: Q4 2025


Cellebrite DI Earnings Call Transcript: Q3 2025

Nov 12, 2025, 5:00 PM EST - 9 months ago

Cellebrite DI Earnings Call Transcript: Q3 2025


Cellebrite DI Earnings release: Q3 2025

Nov 12, 2025, 5:00 PM EST - 9 months ago

Cellebrite DI Earnings release: Q3 2025


Cellebrite DI Slides: Q3 2025

Nov 12, 2025, 5:00 PM EST - 9 months ago

Cellebrite DI Slides: Q3 2025


Cellebrite Announces Third-Quarter 2025 Results

Nov 12, 2025, 4:01 PM EST - 9 months ago

Cellebrite Announces Third-Quarter 2025 Results


Cellebrite DI Earnings Call Transcript: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 1 year ago

Cellebrite DI Earnings Call Transcript: Q2 2025


Cellebrite DI Earnings release: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 1 year ago

Cellebrite DI Earnings release: Q2 2025


Cellebrite DI Slides: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 1 year ago

Cellebrite DI Slides: Q2 2025


Cellebrite Announces Second-Quarter 2025 Results

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Cellebrite Announces Second-Quarter 2025 Results


Cellebrite Names David Barter Chief Financial Officer

Jul 8, 2025, 8:30 AM EDT - 1 year ago

Cellebrite Names David Barter Chief Financial Officer


Cellebrite DI Slides: Investor Presentation

Jun 11, 2025, 9:00 AM EDT - 1 year ago

Cellebrite DI Slides: Investor Presentation


Cellebrite to Acquire Corellium

Jun 5, 2025, 7:30 AM EDT - 1 year ago

Cellebrite to Acquire Corellium


Cellebrite DI Earnings Call Transcript: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

Cellebrite DI Earnings Call Transcript: Q1 2025


Cellebrite DI Earnings release: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

Cellebrite DI Earnings release: Q1 2025


Cellebrite DI Slides: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

Cellebrite DI Slides: Q1 2025


Cellebrite Announces First-Quarter 2025 Results

May 14, 2025, 7:00 AM EDT - 1 year ago

Cellebrite Announces First-Quarter 2025 Results


Cellebrite Files its 2024 Annual Report on Form 20-F

Mar 18, 2025, 9:00 AM EDT - 1 year ago

Cellebrite Files its 2024 Annual Report on Form 20-F


Cellebrite DI Earnings Call Transcript: Q4 2024

Feb 13, 2025, 8:30 AM EST - 1 year ago

Cellebrite DI Earnings Call Transcript: Q4 2024


Cellebrite DI Annual report: Q4 2024

Feb 13, 2025, 8:30 AM EST - 1 year ago

Cellebrite DI Annual report: Q4 2024


Cellebrite DI Earnings release: Q4 2024

Feb 13, 2025, 8:30 AM EST - 1 year ago

Cellebrite DI Earnings release: Q4 2024


Cellebrite DI Slides: Q4 2024

Feb 13, 2025, 8:30 AM EST - 1 year ago

Cellebrite DI Slides: Q4 2024


kej32
kej32 Aug. 19 at 3:37 PM
$CLBT The expansion has begun! https://x.com/cellebrite/status/2090057485667188960?s=46&t=mTiPkuwMEr3cC5hX_MpFMA
0 · Reply
updiddlyup
updiddlyup Aug. 19 at 1:29 PM
$CLBT official https://apfs-cloud.dhs.gov/record/73738/public-print/
0 · Reply
updiddlyup
updiddlyup Aug. 19 at 1:09 PM
$CLBT Cellebrite is the chosen product solution already for the $100M project. The competing vendors are bidding for the actual rollout of the product. https://www.highergov.com/contract-forecast/cellebrite-indefinite-delivery-indefinite-quanti-1142655/#overview
0 · Reply
updiddlyup
updiddlyup Aug. 18 at 9:52 PM
$CLBT Institutions taking advantage. Voss Capital LP (Travis W. Cocke, Houston) has crossed 5% in Cellebrite. Aggregate 12,700,000 shares, 5.1% of the 250,785,933 ordinary shares outstanding as of 30 June 2026, per the share count in Exhibit 99.1 of the 6-K filed 13 August.
0 · Reply
updiddlyup
updiddlyup Aug. 18 at 9:20 PM
$CLBT 😎 The September federal contract https://fedscoop.com/wp-content/uploads/sites/5/2026/05/APFS-050626-Cellebrite-ICE.pdf DHS Acquisition Planning Forecast System record F2026073738, published 6 May 2026. ICE/HSI requirement out of the DHS Cyber Crimes Center. Titled as a brand name five-year Cellebrite IDIQ. Estimated dollar range $50M to $100M. Firm fixed price. Competition marked yes. NAICS 334290. Place of performance Fairfax VA. Estimated solicitation release 16 July 2026. Anticipated award Q4 FY2026. Contract complete 29 September 2031. Q4 FY2026 ends 30 September. The solicitation was due out a month ago, so on the forecast schedule roughly six weeks remain in the award window. The record description states Cellebrite mobile forensic products are the most widely deployed computer forensic tool within HSI, covering phones, tablets and unmanned aerial vehicles, across both domestic and international offices.
1 · Reply
updiddlyup
updiddlyup Aug. 18 at 8:14 PM
$CLBT that spike right at the end there is institutional block trades wiping out liquidity. [15:51:02 EST] 🟢 BLOCK TRADE: 45,000 shares @ $10.74 (Value: ~$483,300) [15:55:18 EST] 🟢 BLOCK TRADE: 72,500 shares @ $10.85 (Value: ~$786,625) [15:59:45 EST] 🔥 SWEEDING ORDER: 110,000 shares @ $10.98 (Value: ~$1,207,800)
2 · Reply
Eelco1054
Eelco1054 Aug. 17 at 3:34 PM
$CLBT Added
0 · Reply
Invest2Growcom
Invest2Growcom Aug. 17 at 2:19 PM
$CLBT I really love this stock at these levels. It has robust fundamentals and the valuation is yummy (NFA).
0 · Reply
punktdot
punktdot Aug. 17 at 2:16 PM
$CLBT it doesn't make any sense, who would be selling now?
1 · Reply
updiddlyup
updiddlyup Aug. 17 at 1:30 PM
$CLBT PING! darn I wanted more at 11. Will have to pay a bit more now
1 · Reply
InvestorCastle
InvestorCastle Aug. 16 at 7:29 PM
$CLBT $APP Glad I bought in here last week. Sometimes the market overreacts. This is certainly the case.
0 · Reply
updiddlyup
updiddlyup Aug. 14 at 9:43 PM
$CLBT Get some cyber forensics company awaiting 9 figure contract from Govt and massively oversold on the last drop. Huge cash reserves and contracts incoming. See my thread there. $GRRR $DGXX $NBIS
0 · Reply
updiddlyup
updiddlyup Aug. 14 at 8:35 PM
$AIOT I'm out. The only reason I sold my holdings here was a better recovery potential at $CLBT where I have placed the proceeds. The same kind of drop just happened there but their business is a far better prospect. You can find my thread on that board. They have massive amounts of FCF and quite a few potential news streams coming soon. Govt contracts with Cyber Forensics can't really go wrong. GLA
3 · Reply
updiddlyup
updiddlyup Aug. 14 at 8:08 PM
$CLBT POTENTIAL THREAD 1. First-Ever Nine-Figure Deal PotentialDuring the August 2026 earnings call, management revealed that Cellebrite has been shortlisted for its first-ever nine-figure ($100M+) government program. Because public sector procurement is notoriously slow, an official press release confirming a win of this magnitude would serve as a massive upward catalyst for the stock.
2 · Reply
InvestorCastle
InvestorCastle Aug. 14 at 7:43 PM
$CLBT Just joined the party. Very oversold.
0 · Reply
updiddlyup
updiddlyup Aug. 14 at 7:40 PM
$CLBT RSI 21 heavily oversold so I'm aboard the recovery plane.
0 · Reply
henrycid
henrycid Aug. 14 at 2:54 PM
$CLBT couldn't be more bullish at this price, bottom is in
0 · Reply
MesserschmittBavaria
MesserschmittBavaria Aug. 14 at 1:38 PM
$CLBT 1 M exchanged in 6 minutes 💪
0 · Reply
punktdot
punktdot Aug. 14 at 9:36 AM
$CLBT ok, after letting it sit for a night and looking at the data again, it's such a crazy overreaction, I honestly don't know what happened. Let's look at the facts again: - revenue grew 16% - ARR still grew 21% YoY - net retention improved from 115% to 117% - adjusted EBITDA beat the prior $29–31M guidance at $31.8M - management raised full-year EBITDA guidance - Genesis has begun monetizing - Cellebrite has landed its first significant FedRAMP Guardian deal The reason it dropped was because revenue didn't grow as fast as expected. Which isn't great, but never warrants a 30% haircut.
1 · Reply
Patelanks
Patelanks Aug. 14 at 9:26 AM
$CLBT $15 in 2 week
0 · Reply
ShKumaresan
ShKumaresan Aug. 14 at 2:34 AM
$CLBT $GME $XPEV Why Did CLBT, XPEV, GME Stocks Hit 52-Week Lows Today? https://stocktwits.com/news-articles/markets/equity/why-did-clbt-xpev-gme-stocks-hit-52-week-lows-today/cZotTwvRJiE
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 14 at 2:34 AM
Why Did CLBT, XPEV, GME Stocks Hit 52-Week Lows Today? $CLBT $GME $XPEV https://stocktwits.com/news/equity/markets/why-did-clbt-xpev-gme-stocks-hit-52-week-lows-today/cZotTwvRJiE
0 · Reply